Sun Pharmaceutical Industries Limited

NSEI:SUNPHARMA Voorraadrapport

Marktkapitalisatie: ₹4.4t

Sun Pharmaceutical Industries Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Sun Pharmaceutical Industries is de winst gegroeid met een gemiddeld jaarlijks percentage van 28.5%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 13.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 10.4% per jaar. Het rendement op eigen vermogen van Sun Pharmaceutical Industries is 16%, en het heeft een nettomarge van 22%.

Belangrijke informatie

28.5%

Groei van de winst

28.6%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie17.5%
Inkomstengroei10.4%
Rendement op eigen vermogen16.0%
Nettomarge22.0%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Sun Pharmaceutical Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Oct 31
Sun Pharmaceutical Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

We Ran A Stock Scan For Earnings Growth And Sun Pharmaceutical Industries (NSE:SUNPHARMA) Passed With Ease

Oct 21
We Ran A Stock Scan For Earnings Growth And Sun Pharmaceutical Industries (NSE:SUNPHARMA) Passed With Ease

Pinning Down Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) P/E Is Difficult Right Now

Aug 24
Pinning Down Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) P/E Is Difficult Right Now

Sun Pharmaceutical Industries Limited Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next

Aug 06
Sun Pharmaceutical Industries Limited Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next

This Is The Reason Why We Think Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Might Be Underpaid

Jul 30
This Is The Reason Why We Think Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Might Be Underpaid

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Ticks All The Boxes When It Comes To Earnings Growth

Jun 30
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Ticks All The Boxes When It Comes To Earnings Growth

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Jun 12
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 25
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Price Is Out Of Tune With Earnings

May 22
Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Price Is Out Of Tune With Earnings

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Mar 13
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet

Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Feb 03
Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today

Jan 05
Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today

Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely

Dec 18
Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely

Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?

Oct 04
Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?

Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?

Jul 03
Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?

We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease

Jun 15
We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease

Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?

Mar 14
Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?

Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50

Feb 03
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well

Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?

Oct 13
Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?

These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely

Sep 04
These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely

Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Aug 05
Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's

Opbrengsten en kosten

Hoe Sun Pharmaceutical Industries geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NSEI:SUNPHARMA Opbrengsten, kosten en inkomsten (INR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 24503,077110,54196,6840
30 Jun 24492,088103,89595,5510
31 Mar 24484,96995,76495,0250
31 Dec 23474,44689,06393,6810
30 Sep 23463,04985,48590,4190
30 Jun 23450,64884,35286,8210
31 Mar 23438,85784,73683,5490
31 Dec 22424,01842,11980,5490
30 Sep 22410,23941,04778,6880
30 Jun 22396,97538,89476,1690
31 Mar 22386,54532,72773,5440
31 Dec 21377,30764,44171,3540
30 Sep 21367,04462,37870,0490
30 Jun 21356,31660,03668,6190
31 Mar 21334,98129,03869,0420
31 Dec 20331,60124,09568,7290
30 Sep 20324,78214,70667,0160
30 Jun 20320,4847,21965,8100
31 Mar 20328,37537,64963,9860
31 Dec 19318,16540,01064,1490
30 Sep 19314,01843,29363,6080
30 Jun 19302,16129,95662,1010
31 Mar 19290,65926,65461,0270
31 Dec 18288,05234,37958,5390
30 Sep 18277,18224,38057,3160
30 Jun 18275,04835,69054,7020
31 Mar 18264,15520,95754,8140
31 Dec 17263,81120,76354,0070
30 Sep 17276,53031,82752,4320
30 Jun 17295,31045,05749,9290
31 Mar 17313,08169,64450,2850
31 Dec 16319,18573,27049,9860
30 Sep 16311,43174,00049,2120
30 Jun 16297,51261,93748,0120
31 Mar 16281,08645,45749,0760
31 Dec 15266,28138,91595,3690
30 Sep 15264,67028,70295,0000
30 Jun 15276,42238,15045,6080
31 Mar 15273,92045,39446,4830
31 Dec 14170,76559,14145,5860
30 Sep 14170,83560,20245,0360
30 Jun 14165,25058,10044,6800
31 Mar 14160,80431,41544,0400
31 Dec 13150,93326,10435,0710

Kwaliteitswinsten: SUNPHARMA heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (22%) SUNPHARMA } zijn hoger dan vorig jaar (18.5%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van SUNPHARMA is de afgelopen 5 jaar aanzienlijk gegroeid met 28.5% per jaar.

Versnelling van de groei: De winstgroei van SUNPHARMA over het afgelopen jaar ( 29.3% ) overtreft het 5-jarig gemiddelde ( 28.5% per jaar).

Winst versus industrie: De winstgroei SUNPHARMA over het afgelopen jaar ( 29.3% ) overtrof de Pharmaceuticals -sector 19.1%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 16% ) van SUNPHARMA wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden